002603:SZSEShijiazhuang Yiling Pharmaceutical Co., Ltd. Class A Analysis
Data as of 2026-03-17 - not real-time
CN¥16.89
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Valuation: The stock trades above its discounted cash‑flow fair value, indicating a premium price, yet its forward price‑to‑earnings multiple sits comfortably below the industry average, suggesting relative cheapness. A low beta points to limited systematic risk, while the dividend yield is modest and the payout ratio is effectively zero, raising questions about sustainability.
Technical outlook: The MACD histogram has turned positive, delivering a bullish signal, whereas the RSI remains in a neutral zone. The price is hovering just above a key support level with a nearby resistance ceiling, and a decreasing volume trend hints at waning short‑term momentum, leaving the overall trend neutral.
Technical outlook: The MACD histogram has turned positive, delivering a bullish signal, whereas the RSI remains in a neutral zone. The price is hovering just above a key support level with a nearby resistance ceiling, and a decreasing volume trend hints at waning short‑term momentum, leaving the overall trend neutral.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Neutral technical positioning near support
- Bullish MACD but decreasing volume
- Modest dividend yield with sustainability concerns
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Forward earnings outlook turning positive
- Valuation advantage versus industry peers
- Strong cash generation and low leverage
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Ongoing regulatory scrutiny in Chinese pharma
- Persistently negative profitability metrics
- Uncertain dividend sustainability despite cash strength
Key Metrics & Analysis
Financial Health
Revenue Growth3.80%
Profit Margin-4.64%
P/E Ratio18.0
ROE-2.58%
ROA-1.48%
Debt/Equity0.28
P/B Ratio2.6
Op. Cash FlowCN¥1.6B
Free Cash FlowCN¥1.5B
Industry P/E26.2
Technical Analysis
TrendNeutral
RSI42.9
SupportCN¥16.28
ResistanceCN¥18.05
MA 20CN¥17.12
MA 50CN¥17.57
MA 200CN¥16.73
MACDBullish
VolumeDecreasing
Fear & Greed Index80.82
Valuation
Fair ValueCN¥15.35
Target PriceCN¥21.04
Upside/Downside24.54%
GradeFair
TypeBlend
Dividend Yield1.76%
Risk Assessment
Beta0.10
Volatility27.37%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.